J. Fuentes et al. / Carbohydrate Research 319 (1999) 192–198
195
346 ([M+Na]+). HREIMS: m/z obsd
308.0548, calcd for C9H14N3O7S 308.0552
([M−CH3]+). Anal. Calcd for C10H17O7N3S:
C, 37.14; H, 5.30; N, 13.00; S, 9.92. Found: C,
37.32; H, 5.23; N, 12.66; S, 10.14.
3-O-Acetyl-6-azido-6-deoxy-1,2-O-isopropy-
lidene-h- -glucofuranose (6).—Syrup (238 mg,
D
83%); [h]2D3 +9° (c 0.8, CH2Cl2); IR wmax 3472,
2104, 1742, 1375, 1228, 1084, 1024 and 864
cm−1; 1H NMR (500 MHz, CDCl3): l 5.89 (d,
1 H, J1,2 3.6 Hz, H-1), 5.27 (d, 1 H, J3,4 2.6
Hz, H-3), 4.58 (d, 1 H, H-2), 4.17 (dd, 1 H,
J4,5 9.2 Hz, H-4), 3.72 (ddd, 1 H, J5,6a 2.7, J5,6b
6.4 Hz, H-5), 3.58 (dd, 1 H, J6a,6b 12.7 Hz,
H-6a), 3.47 (dd, 1 H, H-6b), 2.16 (s, 3 H,
COCH3), 1.53, 1.32 (2 s, each 3 H, CMe2)
3,6-Diazido-3,6-dideoxy-1,2-O-isopropyli-
dene-h- -allofuranose (9).—Amorphous solid
D
(216 mg, 80%); [h]2D6+128° (c 1.0, CH2Cl2);
IR wmax 2108, 1379, 1262, 1107, 1026, and 872
cm−1; 1H NMR (500 MHz, CDCl3): l 5.80 (d,
1 H, J1,2 3.6 Hz, H-1), 4.77 (dd, 1 H, J2,3 4.7
Hz, H-2), 4.08-4.05 (m, 1 H, H-4), 4.07–4.03
(m, 1 H, H-5), 3.58 (dd, 1 H, J3,4 8.9 Hz, H-3),
3.54 (dd, 1 H, J5,6a 7.6, J6a,6b 12.7 Hz, H-6a),
3.45 (dd, 1 H, J5,6b 3.7 Hz, H-6b), 2.37 (d, 1
H, J5,OH 3.5 Hz, OH), 1.59, 1.38 (2 s, each 3
H, CMe2) ppm; 13C NMR (125.7 MHz,
CDCl3): l 113.4 (CMe2), 104.1 (C-1), 80.6
(C-2), 77.7 (C-4), 70.3 (C-5), 60.2 (C-3), 52.7
(C-6), 26.4 (2C, CMe2) ppm; FABMS: m/z
293 ([M+Na]+). Anal. Calcd for C9H14N6O4:
C, 40.00; H, 5.22; N, 31.10. Found: C, 40.18;
H, 4.93; N, 30.75.
13
ppm; C NMR (125.7 MHz, CDCl3): l 171.2
(CO), 112.4 (CMe2), 104.7 (C-1), 83.0 (C-2),
79.3 (C-4), 76.4 (C-3), 67.5 (C-5), 53.9 (C-6),
26.5, 26.1 (CMe2), 20.6 (COCH3) ppm;
FABMS: m/z 310 ([M+Na]+). Anal. Calcd
for C11H17N3O6: C, 45.99; H, 5.96; N, 14.63.
Found: C, 46.24; H, 5.58; N, 14.28.
6-Azido-3-O-benzyl-6-deoxy-1,2-O-isopropy-
lidene-h- -glucofuranose (7).—Syrup (265 mg,
D
79%); [h]2D8−54° (c 1.1, CH2Cl2); IR wmax
3493, 2104, 1080 and 1022 cm−1; lit. [17]
1
3500(OH) and 2100(N3); H NMR (500 MHz,
CDCl3): l 7.39–7.33 (m, 5 H, Ar), 5.93 (d, 1
H, J1,2 3.7 Hz, H-1), 4.75 (d, 1 H, JH,H 11.8
Hz, CHHPh), 4.64 (d, 1 H, H-2), 4.53 (d, 1 H,
CHHPh), 4.09 (m, 3 H, H-3, H-4, and H-5),
3.54 (m, 1 H, H-6a), 3.42 (dd, 1 H, J5,6b 5.4,
J6a,6b 12.5 Hz, H-6b), 2.28 (d, 1 H, J5,OH 4.2
Hz, OH), 1.49, 1.33 (2 s, each 3 H, CMe2)
ppm; 13C NMR (125.7 MHz, CDCl3): l
136.8–127.9 (6 C, Ar), 111.9 (CMe2), 105.1
(C-1), 81.9 (C-2), 81.4 (C-3*), 79.8 (C-4*),
71.9 (CH2Ph) 68.3 (C-5), 54.3 (C-6), 26.7, 26.2
(CMe2) ppm; HREIMS m/z obsd 320.1243,
calcd for C15H18N3O5 320.1246 ([M−CH3]+).
6-Azido-6-deoxy-1,2-O-isopropylidene-3-O-
6-Azido-6-deoxy-1,2-O-isopropylidene-h- -
D
glucofuranose (10).—[h]2D7+1° (c 0.6, Me2CO);
lit. [15] [h]2D7+2.48° (Me2CO).
6-O-Acetyl-5-azido-5-deoxy-1,2-O-isopropy-
lidene-i- -idofuranose (11).—Solid (201 mg,
L
70%); mp 72–74 °C (Et2O–light petroleum
ether); [h]2D6= −57° (c 1.0, CH2Cl2); IR wmax
3443, 2104, 1740, 1373, 1260, 1082 and 1020
cm−1; 1H NMR (500 MHz, CDCl3): l 5.98 (d,
1 H, J1,2 3.7 Hz, H-1), 4.53 (d, 1 H, H-2), 4.32
(dd, 1 H, J6a,6b 11.7 Hz, H-6a), 4.22 (m, 1 H,
H-3), 4.14 (dd, 1 H, H-6b), 4.13 (dd, 1 H, J3,4
2.5 Hz, H-4), 3.94 (t d, 1 H, J4,5 7.6, J5,6a 3.4,
J5,6b 7.6, Hz H-5), 2.66 (d, 1 H, OH), 2.13 (s,
3 H, COCH3), 1.50, 1.32 (2 s, each 3 H,
CMe2); 13C NMR (125.7 MHz, CDCl3): l
170.9 (CO), 112.0 (CMe2), 104.5 (C-1), 85.2
(C-2), 79.6 (C-4), 75.2 (C-3), 63.8 (C-6), 59.8
(C-5), 26.7, 26.1 (CMe2), 20.6 (COCH3);
FABMS: m/z 310 ([M+Na]+). Anal. Calcd
for C11H17N3O6: C, 45.99; H, 5.96; N, 14.63.
Found: C, 46.04; H, 5.94; N, 14.77.
methanesulfonyl-h-D-glucofuranose
(8).—
Syrup (284 mg, 88%); [h]2D1−27° (c 1.1,
CH2Cl2) IR wmax 3528, 2106, 1360, 1171, 1088,
1020, 943 and 851 cm−1; 1H NMR (300 MHz,
CDCl3): l 5.93 (d, 1 H, J1,2 3.6 Hz, H-1), 5.14
(d, 1 H, J3,4 2.7 Hz, H-3), 4.75 (d, 1 H, H-2),
4.22 (dd, 1 H, J4,5 9.3 Hz, H-4), 3.97 (ddd, 1
H, J5,6a 2.8, J5,6b 6.0 Hz, H-5), 3.64 (dd, 1 H,
J6a,6b 12.7 Hz, H-6a), 3.52 (dd, 1 H, H-6b),
3.15 (s, 3 H, Ms), 1.52, 1.33 (2 s, each 3 H,
5-Azido-5-deoxy-1,2-O-isopropylidene-i- -
L
idofuranose (12).—[h]2D1−77° (c 1.2, MeOH);
13
CMe2) ppm; C NMR (75.4 MHz, CDCl3): l
lit. [15] [h]2D0−77.0 (c 2.6, MeOH).
112.8 (CMe2), 104.9 (C-1), 83.1 (C-2), 81.1
(C-3), 78.7 (C-4), 67.3 (C-5), 54.0 (C-6), 38.0
(OMs), 26.5, 26.1 (CMe2) ppm; FABMS: m/z
General procedure for the preparation of
amino deri6ati6es 13–15.—A mixture of the